Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bluejay Diagnostics, Inc. (BJDX : NSDQ)

• Company Description    Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. Number of Employees: 16

• Price / Volume Information    Yesterday's Closing Price: $0.22 Daily Weekly Monthly 20 Day Moving Average: 1,287,319 shares Shares Outstanding: 20.46 (millions) Market Capitalization: $4.60 (millions) Beta: 0.82 52 Week High: $1.83 52 Week Low: $0.19 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.42% -30.17% 12 Week -63.12% -65.76% Year To Date -40.77% -46.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MASSACHUSETTS AVENUE SUITE 203 - ACTON,MA 01720 USA ph: 844-327-7078 fax: - ir@bluejaydx.com https://bluejaydx.com

• General Corporate Information    Officers Neil Dey - Chief ExecutiveOfficer Douglas C. Wurth - Chairman of the Board of Directors Kenneth Fisher - Chief Financial Officer Donald R. Chase - Director Svetlana Dey - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 095633103 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/23 Next Expected EPS Date: 07/25/23 Share - Related Items Shares Outstanding: 20.46 Most Recent Split Date: (:1) Beta: 0.82 Market Capitalization: $4.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.29 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/25/23

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.50 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -20.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/23 - -74.93 12/31/22 - -59.90 09/30/22 - -47.07 ROA 03/31/23 - -65.90 12/31/22 - -53.78 09/30/22 - -43.59 Current Ratio 03/31/23 - 6.27 12/31/22 - 7.19 09/30/22 - 9.15 Quick Ratio 03/31/23 - 6.27 12/31/22 - 7.19 09/30/22 - 9.15 Operating Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Net Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Pre-Tax Margin 03/31/23 - -3,945.38 12/31/22 - -3,733.74 09/30/22 - -3,361.77 Book Value 03/31/23 - 0.45 12/31/22 - 0.57 09/30/22 - 0.69 Inventory Turnover 03/31/23 - 1.19 12/31/22 - 0.51 09/30/22 - 0.51 Debt-to-Equity 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00 Debt-to-Capital 03/31/23 - 0.00 12/31/22 - 0.00 09/30/22 - 0.00

Powered by Zacks Investment Research ©